StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Nilesh Jain, Centrum Broking

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Swing (≤2wk))1 Sept 2026via Zee Business (Live)

Entry₹870.2Inferred
Target₹900
Total upside +3.42% (call closed)
Stop loss₹845-2.90% risk
Exit₹8459 Sept 2026, 10:00 am
Stop-loss hit-2.90%
Follow Nilesh Jain for new calls(32% target hit, 138 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

Aarti Pharmalabs targets 15-18% revenue and EBITDA growth over 3-4 years

NewsGoogle News·30 Aug · 1w ago

(opens in new tab)

Aarti Pharmalabs: FY26 Results Announced

NewsGoogle News·29 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from Nilesh Jain, Centrum Broking

Every call and its outcome